The British journal of surgery
-
Randomized Controlled Trial Multicenter Study
Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery.
The aim was to evaluate the cost-effectiveness and cost-utility of ursodeoxycholic acid (UDCA) prophylaxis for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass (RYGB) in patients without gallstones before surgery. ⋯ UDCA prophylaxis after RYGB in patients without gallstones before surgery was cost-effective.